CCAIM
Novel AI to transform healthcare
An extensive new study published in Nature Machine Intelligence shows that a prognostic tool developed by the van der Schaar Lab can recommend therapies for breast cancer patients more reliably than methods …
Using AI with home monitoring to predict sudden dips in the health of adults with cystic fibrosis has been awarded ‘Phase 2’ funding by the government. A pioneering artificial intelligence …
With the help of artificial intelligence, patients should find out whether their rash or a birthmark is dangerous. Experts recognize the advantages of such a tool, but emphasize that it cannot replace a doctor.
The Cambridge Centre for AI in Medicine develops pioneering AI and machine learning technologies with the goal of transforming biomedical science, medicine and healthcare. Another of our goals is to …
Today the University of Cambridge announces a five-year agreement with AstraZeneca and GSK to fund the Cambridge Centre for AI in Medicine (CCAIM). For the 5-year duration, AstraZeneca and GSK …
The question of which patient should receive a life-saving donor organ is one of the thorniest in medicine. Donor organs are a scarce resource, each one as unique as the …
World-leading AI technology developed at the University of Cambridge by the directors of the Cambridge Centre for AI in Medicine and their colleagues offers a glimpse of the future of …
World-leading expertise in healthcare-focused machine learning combined with the world’s largest, high-quality cancer data collection service could lead to a quantum leap in personalised medicine. (This article, featuring the work …
